Video from ECR 2018: Alexander Radbruch on gadolinium retention

The debate over the safety of gadolinium-based contrast agents for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, JD, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic.

Video from ECR 2018: Alexander Radbruch on gadolinium retention VIENNA – The debate over the safety of gadolinium-based contrast agents (GBCAs) for MRI shows no sign of going away, and U.S.-style lawsuits filed against radiologists and vendors in Europe is now a distinct possibility. Dr. Alexander Radbruch, head of neuro-oncologic imaging at the German Cancer Research Center in Heidelberg and University Hospital Essen in Germany, is both a lawyer and a radiologist, and he presents his views and ideas on this controversial topic. Caption: Dr. Alexander Radbruch from Heidelberg and Essen Video produced by Christof. G. Pelz I GRAFIFANT Creation. Grafik. Photo I www.grafifant.at
More in Conference
HRCT Fellowship
December 10, 2023December 12, 2023
Pancreas Imaging Fellowship
November 19, 2023November 21, 2023
Artificial intelligence in radiology workflow
November 14, 2023November 16, 2023
Online Pelvic Floor Imaging Fellowship
November 19, 2023November 21, 2023
Paediatric Neuroradiology Fellowship
December 17, 2023December 19, 2023
Page 1 of 125
Next Page